General Pharmaceuticals Market Research Reports & Industry Analysis
General Pharmaceuticals Industry Research & Market Reports
-
Castor Oil and Derivatives
... 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Sebacic Acid, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$557.8 Million by the ... Read More
-
Zinc Stearates
... CAGR of 7.0% over the analysis period 2024-2030. Polymer & Rubber, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$1.3 Billion by the end of the ... Read More
-
Iridium
... 5.3% over the analysis period 2024-2030. Automobile, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$2.0 Billion by the end of the analysis period. Growth in ... Read More
-
Sodium Alginate
... CAGR of 5.0% over the analysis period 2024-2030. Stabilizers, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$137.4 Million by the end of the analysis period. ... Read More
-
Binder Excipients
... CAGR of 5.3% over the analysis period 2024-2030. Cellulosics, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$1.0 Billion by the end of the analysis period. ... Read More
-
Curcumin
... 8.7% over the analysis period 2024-2030. Conventional Curcumin, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$139.3 Million by the end of the analysis period. Growth ... Read More
-
Cannabis Edibles
... CAGR of 22.0% over the analysis period 2024-2030. Solid Edibles, one of the segments analyzed in the report, is expected to record a 22.2% CAGR and reach US$38.2 Billion by the end of the analysis ... Read More
-
Empty Capsules
... CAGR of 5.5% over the analysis period 2024-2030. Gelatin, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$3.5 Billion by the end of the analysis period. ... Read More
-
Glutamic Acid
... CAGR of 7.9% over the analysis period 2024-2030. Food & Beverage, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$14.6 Billion by the end of the ... Read More
-
Anti-Ischemic Agents
... CAGR of 6.3% over the analysis period 2024-2030. The U.S. Market is Estimated at US$94.1 Million While China is Forecast to Grow at 9.7% CAGR The Anti-Ischemic Agents market in the U.S. is estimated at ... Read More
-
Docosahexaenoic Acid (DHA)
... at a CAGR of 10.9% over the analysis period 2024-2030. Fish Oil DHA, one of the segments analyzed in the report, is expected to record a 12.2% CAGR and reach US$5.3 Billion by the end ... Read More
-
Synthetic Betaine
... CAGR of 5.4% over the analysis period 2024-2030. Food & Beverages, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$1.2 Billion by the end of the ... Read More
-
Glutamine
... 2.5% over the analysis period 2024-2030. Nutraceutical, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$106.0 Million by the end of the analysis period. Growth in ... Read More
-
Healthcare Supply Chain Management
... 2030, growing at a CAGR of 10.2% over the analysis period 2024-2030. Software, one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$2.3 Billion by the end ... Read More
-
DPP-IV Inhibitors
... CAGR of 1.7% over the analysis period 2024-2030. The U.S. Market is Estimated at US$3.5 Billion While China is Forecast to Grow at 1.7% CAGR The DPP-IV Inhibitors market in the U.S. is estimated at ... Read More
-
CBD Nutraceuticals
... CAGR of 18.1% over the analysis period 2024-2030. CBD Tinctures, one of the segments analyzed in the report, is expected to record a 16.2% CAGR and reach US$11.9 Billion by the end of the analysis ... Read More
-
Marijuana Drying and Curing Equipment
... Million by 2030, growing at a CAGR of 9.5% over the analysis period 2024-2030. The U.S. Market is Estimated at US$55.2 Million While China is Forecast to Grow at 8.7% CAGR The Marijuana Drying and ... Read More
-
High Potency APIs (HPAPIs)
... 2030, growing at a CAGR of 8.5% over the analysis period 2024-2030. Innovative HPAPIs, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$31.4 Billion by the ... Read More
-
Insoluble Dietary Fibers
... at a CAGR of 8.0% over the analysis period 2024-2030. Cellulose, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$1.9 Billion by the end of the ... Read More
-
Oral Solid Dosage Forms (OSDF) and Pharma Excipients
... 2024, is expected to reach US$1.8 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Polymers, one of the segments analyzed in the report, is expected to record a 6.2% ... Read More
-
Constipation Treatment
... CAGR of 5.9% over the analysis period 2024-2030. Laxatives, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$12.3 Billion by the end of the analysis period. ... Read More
-
Potassium Iodide
... CAGR of 6.3% over the analysis period 2024-2030. X-Ray Contrast Media, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$627.6 Million by the end of the ... Read More
-
Excipients
... 4.6% over the analysis period 2024-2030. Polymers, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$4.4 Billion by the end of the analysis period. Growth in ... Read More
-
Lifestyle Drugs
... CAGR of 3.1% over the analysis period 2024-2030. Obesity, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$21.4 Billion by the end of the analysis period. ... Read More
-
Glucose, Dextrose, and Maltodextrin
... 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Glucose, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$32.3 Billion by the end ... Read More
Research Assistance
